食管癌的治疗,目前仍以手术为首选。极早期病例五年生存率高达90.3%,但一般病例手术后五年生存率多为25%左右。既使是早期病例,有的在术后不久就发生转移,因此,目前总的趋势是综合治疗。药物加放射,药物加手术以及联合中西医等方法已广泛应用于临床。近年来,经内镜注射药物和激光治疗对本病的治疗增添了新的手段。 The treatment of esophageal cancer is still the first choice for surgery. The five-year survival rate for very early cases is as high as 90.3%, but the general survival rate of postoperative patients is about 25%. Even though it is an early case, some of them metastasize shortly after surgery. Therefore, the general trend is comprehensive treatment. Drug plus radiation, drug plus surgery, and combined Chinese and Western medicine have been widely used in clinical practice. In recent years, endoscopic injection of drugs and laser treatment have added new means to the treatment of the disease.